SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 37,417.85 |
| Enterprise Value ($M) | 44,368.74 |
| Book Value ($M) | 10,758.50 |
| Book Value / Share | 69.91 |
| Price / Book | 3.44 |
| NCAV ($M) | -6,346.50 |
| NCAV / Share | -41.24 |
| Price / NCAV | -5.82 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.33 |
| Return on Assets (ROA) | 0.23 |
| Return on Equity (ROE) | 0.45 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.79 |
| Current Ratio | 2.06 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 7,843.10 |
| Assets | 24,934.10 |
| Liabilities | 14,189.60 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 14,377.90 |
| Operating Income | 7,042.60 |
| Net Income | 5,888.50 |
| Earnings Per Share Diluted | 31.42 |
| Earnings Per Share Basic | 31.47 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 7,078.60 |
| Cash from Investing | 470.50 |
| Cash from Financing | 470.50 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 7.68 | -8.57 | |
| 13G/A | Primecap Management Co/ca/ | 8.42 | 3.14 | |
| 13G/A | BlackRock Inc. | 8.70 | -5.49 | |
| 13G/A | Fmr Llc | 3.87 | -34.93 | |
| 13G/A | Price T Rowe Associates Inc /md/ | 2.80 | ||
| 13G/A | Vanguard Chester Funds | 4.36 | ||
| 13G/A | Capital Research Global Investors | 4.60 | ||
| 13G/A | Clearbridge Investments, LLC | 4.90 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| Quarterly Report – 10-Q | ||
| Quarterly Report – 10-Q | ||
| Quarterly Report – 10-Q | ||
| Annual Report – 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 116,252 | 1,168,700 | 9.95 | |
| 183,513 | 2,193,505 | 8.37 | |
| 113,888 | 699,227 | 16.29 | |
(click for more detail) |
|||
(click for list of largest short owners) |
|||
| Similar Companies | |
|---|---|
| BDTX – Black Diamond Therapeutics, Inc. | BFRA – Biofrontera AG |
| BGNE – BeiGene, Ltd. | BIND – BIND Therapeutics, Inc. |
| BIVI – BioVie, Inc. |
Financial data and stock pages provided by
Fintel.io